Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
NNX 0.035 +0.0% ABX 51.85 −0.7% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.99 +10.5% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.155 +29.2% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% NNX 0.035 +0.0% ABX 51.85 −0.7% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.99 +10.5% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.155 +29.2% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0%
Regulatory Routine +

Cannabix Marijuana Breath Test Achieves Major Milestone: Breath Collection Unit Secures UL and CSA Certifications

Cannabix Secures UL/CSA Certs, Clears Path for Gov Tenders Amidst Steady Commercial Rollout

By The Northwire Desk — AI Analysis May 13, 2026 · 08:45 BLO · 0.7 Cannabix Technologies Inc.
Executive Summary
  • Cannabix Technologies Inc. announced that its Breath Collection Unit (BCU), a core component of the Marijuana Breath Test (MBT) system, has achieved UL and CSA electrical safety certifications.
  • Certifications include UL 61010-1 for the United States and CSA 61010-1-12 for Canada.
  • Testing was conducted at an independent ISO/IEC 17025 accredited laboratory.
  • The milestone facilitates access to regulated markets including law enforcement, government agencies, and industrial workplace safety sectors.
  • This enables participation in formal tender processes and approved vendor lists requiring specific safety standards.
  • CEO Rav Mlait stated this reflects a focus on product safety, quality, and regulatory compliance during phased commercial deployment.
Material Impact
  • Incremental Validation: The certification is a logical progression following the FCC/ISED emissions testing passed in December 2025 and the Commercial Launch announced in March 2026. It validates existing hardware for broader market access rather than introducing new technology.
  • Market Access: While positive, the company has already secured commercial deliveries to industrial clients (Virginia) and clinics (Eastern Canada) since March 2026 without this specific certification explicitly highlighted as a blocker previously. This removes friction for government tenders but does not represent a sudden revenue inflection point.
  • Expectations: Given the phased rollout strategy announced in March, regulatory milestones like UL/CSA were anticipated by investors familiar with hardware compliance requirements. The news confirms execution rather than surprising the market with new upside.
  • Stock Impact: Likely neutral to slightly positive as it reinforces the commercialization timeline but does not materially alter the valuation model compared to previous delivery announcements.
BLO · Price
Company Overview
  • Company: Cannabix Technologies Inc., a Canadian medical device company focused on breath-based drug testing technology.
  • Flagship Project: Marijuana Breath Test (MBT) system.
    • Components: Breath Collection Unit (BCU) hardware and proprietary Breath Cartridges.
    • Function: Detects delta-9 THC in breath within 4 hours of consumption using LC-MS laboratory analysis.
    • Target Markets: Workplace safety, law enforcement, transportation, industrial manufacturing.
  • Secondary Product: BreathLogix Alcohol Screening Devices (unmanned alcohol testing).
  • Technology Status: Patent granted for Contact-Free Breath Analysis (Oct 2025); FCC/ISED compliance passed (Dec 2025); UL/CSA certification achieved (May 2026).
Read the original news release →

More from Cannabix Technologies Inc.

Jun 29, 2026 · 08:45

Cannabix scales its breath-based THC and alcohol screening hardware into global mining and industrial sectors, but revenue remains negligible against operating burn.

Production / Operations Jun 15, 2026 · 08:45

Cannabix Technologies Inc.

M&A / Property May 29, 2026 · 08:45

Cannabix Expands Australian Footprint as MBT Certification Progresses Amidst Volatility

Production / Operations May 04, 2026 · 08:45

Cannabix Executes Commercial Rollout Amidst Dilution Concerns

Production / Operations Apr 20, 2026 · 08:45

Cannabix Breath Test Gains Traction in US Manufacturing Sector Following Commercial Launch

M&A / Property Apr 01, 2026 · 08:45

Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client

Production / Operations